Sequential binding of agonists to the β2 adrenoceptor. Kinetic evidence for intermediate conformational states

Gayathri Swaminath, Yang Kevin Xiang, Tae Weon Lee, Jacqueline Steenhuis, Charles Parnot, Brian K. Kobilka

Research output: Contribution to journalArticle

287 Citations (Scopus)

Abstract

The β2 adrenoreceptor (β2AR) is a prototypical G protein-coupled receptor (GPCR) activated by catecholamines. Agonist activation of GPCRs leads to sequential interactions with heterotrimeric G proteins, which activate cellular signaling cascades, and with GPCR kinases and arrestins, which attenuate GPCR-mediated signaling. We used fluorescence spectroscopy to monitor catecholamine-induced conformational changes in purified β 2AR. Here we show that upon catecholamine binding, β 2ARs undergo transitions to two kinetically distinguishable conformational states. Using a panel of chemically related catechol derivatives, we identified the specific chemical groups on the agonist responsible for the rapid and slow conformational changes in the receptor. The conformational changes observed in our biophysical assay were correlated with biologic responses in cellular assays. Dopamine, which induces only a rapid conformational change, is efficient at activating Gs but not receptor internalization. In contrast, norepinephrine and epinephrine, which induce both rapid and slow conformational changes, are efficient at activating Gs and receptor internalization. These results support a mechanistic model for GPCR activation where contacts between the receptor and structural determinants of the agonist stabilize a succession of conformational states with distinct cellular functions.

Original languageEnglish (US)
Pages (from-to)686-691
Number of pages6
JournalJournal of Biological Chemistry
Volume279
Issue number1
DOIs
StatePublished - Jan 2 2004
Externally publishedYes

Fingerprint

G-Protein-Coupled Receptors
Adrenergic Receptors
Catecholamines
Kinetics
Assays
Chemical activation
Arrestins
G-Protein-Coupled Receptor Kinases
Cell signaling
Heterotrimeric GTP-Binding Proteins
Fluorescence Spectrometry
Fluorescence spectroscopy
Epinephrine
Dopamine
Norepinephrine
Derivatives

ASJC Scopus subject areas

  • Biochemistry

Cite this

Sequential binding of agonists to the β2 adrenoceptor. Kinetic evidence for intermediate conformational states. / Swaminath, Gayathri; Xiang, Yang Kevin; Lee, Tae Weon; Steenhuis, Jacqueline; Parnot, Charles; Kobilka, Brian K.

In: Journal of Biological Chemistry, Vol. 279, No. 1, 02.01.2004, p. 686-691.

Research output: Contribution to journalArticle

Swaminath, Gayathri ; Xiang, Yang Kevin ; Lee, Tae Weon ; Steenhuis, Jacqueline ; Parnot, Charles ; Kobilka, Brian K. / Sequential binding of agonists to the β2 adrenoceptor. Kinetic evidence for intermediate conformational states. In: Journal of Biological Chemistry. 2004 ; Vol. 279, No. 1. pp. 686-691.
@article{872555cfe6864a85bc12c8bcc892e332,
title = "Sequential binding of agonists to the β2 adrenoceptor. Kinetic evidence for intermediate conformational states",
abstract = "The β2 adrenoreceptor (β2AR) is a prototypical G protein-coupled receptor (GPCR) activated by catecholamines. Agonist activation of GPCRs leads to sequential interactions with heterotrimeric G proteins, which activate cellular signaling cascades, and with GPCR kinases and arrestins, which attenuate GPCR-mediated signaling. We used fluorescence spectroscopy to monitor catecholamine-induced conformational changes in purified β 2AR. Here we show that upon catecholamine binding, β 2ARs undergo transitions to two kinetically distinguishable conformational states. Using a panel of chemically related catechol derivatives, we identified the specific chemical groups on the agonist responsible for the rapid and slow conformational changes in the receptor. The conformational changes observed in our biophysical assay were correlated with biologic responses in cellular assays. Dopamine, which induces only a rapid conformational change, is efficient at activating Gs but not receptor internalization. In contrast, norepinephrine and epinephrine, which induce both rapid and slow conformational changes, are efficient at activating Gs and receptor internalization. These results support a mechanistic model for GPCR activation where contacts between the receptor and structural determinants of the agonist stabilize a succession of conformational states with distinct cellular functions.",
author = "Gayathri Swaminath and Xiang, {Yang Kevin} and Lee, {Tae Weon} and Jacqueline Steenhuis and Charles Parnot and Kobilka, {Brian K.}",
year = "2004",
month = "1",
day = "2",
doi = "10.1074/jbc.M310888200",
language = "English (US)",
volume = "279",
pages = "686--691",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "1",

}

TY - JOUR

T1 - Sequential binding of agonists to the β2 adrenoceptor. Kinetic evidence for intermediate conformational states

AU - Swaminath, Gayathri

AU - Xiang, Yang Kevin

AU - Lee, Tae Weon

AU - Steenhuis, Jacqueline

AU - Parnot, Charles

AU - Kobilka, Brian K.

PY - 2004/1/2

Y1 - 2004/1/2

N2 - The β2 adrenoreceptor (β2AR) is a prototypical G protein-coupled receptor (GPCR) activated by catecholamines. Agonist activation of GPCRs leads to sequential interactions with heterotrimeric G proteins, which activate cellular signaling cascades, and with GPCR kinases and arrestins, which attenuate GPCR-mediated signaling. We used fluorescence spectroscopy to monitor catecholamine-induced conformational changes in purified β 2AR. Here we show that upon catecholamine binding, β 2ARs undergo transitions to two kinetically distinguishable conformational states. Using a panel of chemically related catechol derivatives, we identified the specific chemical groups on the agonist responsible for the rapid and slow conformational changes in the receptor. The conformational changes observed in our biophysical assay were correlated with biologic responses in cellular assays. Dopamine, which induces only a rapid conformational change, is efficient at activating Gs but not receptor internalization. In contrast, norepinephrine and epinephrine, which induce both rapid and slow conformational changes, are efficient at activating Gs and receptor internalization. These results support a mechanistic model for GPCR activation where contacts between the receptor and structural determinants of the agonist stabilize a succession of conformational states with distinct cellular functions.

AB - The β2 adrenoreceptor (β2AR) is a prototypical G protein-coupled receptor (GPCR) activated by catecholamines. Agonist activation of GPCRs leads to sequential interactions with heterotrimeric G proteins, which activate cellular signaling cascades, and with GPCR kinases and arrestins, which attenuate GPCR-mediated signaling. We used fluorescence spectroscopy to monitor catecholamine-induced conformational changes in purified β 2AR. Here we show that upon catecholamine binding, β 2ARs undergo transitions to two kinetically distinguishable conformational states. Using a panel of chemically related catechol derivatives, we identified the specific chemical groups on the agonist responsible for the rapid and slow conformational changes in the receptor. The conformational changes observed in our biophysical assay were correlated with biologic responses in cellular assays. Dopamine, which induces only a rapid conformational change, is efficient at activating Gs but not receptor internalization. In contrast, norepinephrine and epinephrine, which induce both rapid and slow conformational changes, are efficient at activating Gs and receptor internalization. These results support a mechanistic model for GPCR activation where contacts between the receptor and structural determinants of the agonist stabilize a succession of conformational states with distinct cellular functions.

UR - http://www.scopus.com/inward/record.url?scp=0345791508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345791508&partnerID=8YFLogxK

U2 - 10.1074/jbc.M310888200

DO - 10.1074/jbc.M310888200

M3 - Article

C2 - 14559905

AN - SCOPUS:0345791508

VL - 279

SP - 686

EP - 691

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 1

ER -